                         SEQUENCE LISTING

<110>  Beijing BJUT Science and Technology Park Co. Ltd
 
<120>  THERAPEUTIC COMPOSITION AND METHOD FOR TREATING CORONAVIRUS INFECTION

<130>  GWPCT21131

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Amino acid sequence of glutathion

<400>  1

Glu Cys Gly 
1           


<210>  2
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Forward primer targeting SARS-COV-2 ORF1a

<400>  2
agaagattgg ttagatgatg atagt                                           25


<210>  3
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse primer targeting SARS-COV-2 ORF1a

<400>  3
ttccatctct aattgaggtt gaacc                                           25


<210>  4
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Probe targeting SARS-COV-2 ORF1a

<400>  4
tcctcactgc cgtcttgttg acca                                            24


<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Substrate for Mpro protease reaction

<400>  5

Glu Ser Ala Thr Leu Gln Ser Gly Leu Ala Lys Ser 
1               5                   10          


<210>  6
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic small peptide

<400>  6

Cys Cys Tyr Gly Gly Pro Lys Lys Lys Arg Lys Pro Gly 
1               5                   10              


